Literature DB >> 9173745

[A nootropic adrenocorticotropin analog 4-10-semax (l5 years experience in its design and study)].

I P Asmarin, V N Nezavibat'ko, N F Miasoedov, A A Kamenskiĭ, I A Grivennikov, M A Ponomareva-Stepnaia, L A Andreeva, A Ia Kaplan, V B Koshelev, T V Riasina.   

Abstract

Semax is one of the rare analogues of regulatory peptides which underwent all stages from fundamental investigations to practical usage. It has been demonstrated that this peptide is capable to stimulate operative memory and attention, to increase resistance to hypoxia and to improve brain circulation in experimental animals and human beings over prolonged period (20-24 h after intranasal administration in doses 0.015-0.050 mg/kg). Semax significantly improves memory and attention in healthy men under extreme conditions of activities. Moreover at present semax is successfully used in treatment of patients with different diseases of CNS. In the majority of cases the peptide exhibited positive effects and in no case it produced negative side actions or complications connected with its administration. There is good reason to believe that medical potentialities of semax have not been exhausted and in future new possibilities of its usage will be revealed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9173745

Source DB:  PubMed          Journal:  Zh Vyssh Nerv Deiat Im I P Pavlova        ISSN: 0044-4677            Impact factor:   0.437


  17 in total

1.  Effects of Semax, a peptide ACTH4-10 analogue, on the respiratory burst in human neutrophils.

Authors:  E I Astashkin; E A Petrov; Y Bespalova; M G Glezer; I A Grivennikov; S V Grachev
Journal:  Dokl Biol Sci       Date:  2001 May-Jun

2.  The heptapeptide SEMAX stimulates BDNF expression in different areas of the rat brain in vivo.

Authors:  O V Dolotov; T S Seredenina; N G Levitskaya; A A Kamensky; L A Andreeva; L Yu Alfeeva; I Yu Nagaev; Yu A Zolotarev; I A Grivennikov; Yu Engele; N F Myasoedov
Journal:  Dokl Biol Sci       Date:  2003 Jul-Aug

3.  The neuroprotective effects of Semax in conditions of MPTP-induced lesions of the brain dopaminergic system.

Authors:  N G Levitskaya; E A Sebentsova; L A Andreeva; L Yu Alfeeva; A A Kamenskii; N F Myasoedov
Journal:  Neurosci Behav Physiol       Date:  2004-05

4.  Effects of Semax on dopaminergic and serotoninergic systems of the brain.

Authors:  K O Eremin; V S Kudrin; I A Grivennikov; N F Miasoedov; K S Rayevsky
Journal:  Dokl Biol Sci       Date:  2004 Jan-Feb

5.  Semax increases erythrocyte deformability in the shearing blood stream in intact rats and rats with cerebral ischemia.

Authors:  O E Fadyukova; A Yu Tyurina; A E Lugovtsov; A V Priezzhev; L A Andreeva; V B Koshelev; N F Myasoedov
Journal:  Dokl Biol Sci       Date:  2011-09-28

6.  Expression changes caused by the peptide semax in the intracellular signal pathway genes in rat hippocamp.

Authors:  T Yu Agapova; Ya V Agniullin; D N Silachev; M I Shadrina; P A Slominsky; S I Shram; S A Limborskaya; N F Myasoedov
Journal:  Dokl Biochem Biophys       Date:  2007 Nov-Dec       Impact factor: 0.788

7.  Effect of neonatal injections of the neuropeptide Semax on cell proliferation in hippocampal dentate area in rats of two genotypes.

Authors:  T V Timoshenko; I I Poletaeva; G V Pavlova; A V Revishchin
Journal:  Dokl Biol Sci       Date:  2009 Jan-Feb

8.  Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.

Authors:  Kirill O Eremin; Vladimir S Kudrin; Pirjo Saransaari; Simo S Oja; Igor A Grivennikov; Nikolay F Myasoedov; Kirill S Rayevsky
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

9.  Adrenocorticotropic hormone protects learning and memory function in epileptic Kcna1-null mice.

Authors:  Morris H Scantlebury; Kyoung-Chul Chun; Shun-Chieh Ma; Jong M Rho; Do Young Kim
Journal:  Neurosci Lett       Date:  2017-02-27       Impact factor: 3.046

10.  Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia.

Authors:  Veronika G Dmitrieva; Oksana V Povarova; Veronika I Skvortsova; Svetlana A Limborska; Nikolai F Myasoedov; Lyudmila V Dergunova
Journal:  Cell Mol Neurobiol       Date:  2009-07-25       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.